By analyzing the TME components of colon cancer in the TCGA database, we found that the expression of DNASE1L3 is decreased in colon cancer and it is associated with prognosis, disease progression, and immune invasion in colon cancer. The gene discussed is DNASE1L3; the disease is malignant colon neoplasm.